Business · 14/05/2025Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for OMVOH Patent Extension
Summary
The FDA has determined the regulatory review period for OMVOH, a human biological product, following a patent extension application submitted to the USPTO, as required by law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →